Dallas-based Spark Biomedical, an innovator in drug-free wearable neurostimulation technology, has closed its $15M Series A fundraising round. Led by Waco-based WAVE Ventures and supported by New York’s Pathway to Cures, the funding will accelerate Spark’s development of its bioelectronic treatments and support its core business focuses of neurological health, hemostasis, and women’s health, the company said....